![Quiver Logo](/static/img/logo-icon.png)
![ACON logo](https://quiver-logos.s3.us-east-2.amazonaws.com/acon.png)
Aclarion, Inc. Common Stock
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACON Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of ACON by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACON's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ACON
Recent picks made for ACON stock on CNBC
ETFs with the largest estimated holdings in ACON
Flights by private jets registered to ACON
![Quiver Logo](/static/img/logo-icon.png)